Travel ConsultNurse Consult Reviewed
- Patient presented for a travel consultation regarding an upcoming two-week holiday to Southeast Asia.
- Countries and regions to be visited: Thailand (Bangkok, Chiang Mai), Vietnam (Hanoi, Ha Long Bay), Cambodia (Siem Reap).
- Duration of stay in each location: Thailand (7 days), Vietnam (5 days), Cambodia (2 days).
- Nature of travel: Leisure/tourism, with planned cultural excursions and some rural exploration.
---
Medical History
- Past medical history: No chronic conditions. History of seasonal allergies (pollen), well-controlled with over-the-counter antihistamines.
- Medications and herbal supplements: Loratadine 10mg daily as needed for allergies. No other chronic medications or herbal supplements.
- Allergies: Penicillin (rash), no known vaccine allergies.
---
Vaccinations
- Current vaccinations: Tetanus (last booster 5 years ago), Hepatitis B (full course completed), MMR (childhood), COVID-19 (completed primary course and one booster).
---
Vaccine Recommendations (based on local travel protocols and WHO guidelines):
- Recommended vaccinations for travel destinations: Hepatitis A, Typhoid, Japanese Encephalitis, and a Tetanus booster due to planned rural activities.
---
Malaria
- Malaria risk for areas: Low to negligible risk in major urban areas. Discussed potential for localized risk in some rural areas of Cambodia, particularly if trekking or staying overnight in less developed regions.
- Malaria medications discussed and associated information: Discussed atovaquone/proguanil 250mg/100mg, one tablet daily, starting 1-2 days before entering a risk area, during stay, and for 7 days after leaving. Patient advised on potential side effects (nausea, diarrhoea) and importance of compliance.
---
Yellow Fever
- Yellow fever vaccination risks, requirements and recommendations discussed at length. WHO Country List (latest update reviewed).
- Yellow Fever vaccine requirement or exemption for destination countries: Not required for Thailand, Vietnam, or Cambodia, as patient is not travelling from an endemic country. No specific exemption certificate needed.
- Vaccination risks including Yellow Fever-Associated Neurotropic Disease (YF-AND) and Viscerotropic Disease (YF-AVD) discussed, including increased age-related risk. NaTHNaC checklist completed with the patient.
---
Travel Advice
- Advice on safe food and water practices: Advised to drink only bottled or purified water, avoid ice in drinks, eat only well-cooked food, avoid raw fruits and vegetables unless peeled by the traveller, and be cautious with street food. Hand hygiene emphasised.
- Insect-borne precautions: Advised use of DEET-containing mosquito repellents (minimum 30%), wearing long sleeves and trousers at dawn and dusk, and sleeping under insecticide-treated mosquito nets if staying in rural or non-air-conditioned accommodation.
- Other relevant travel health advice: Discussed importance of comprehensive travel insurance, carrying a basic first aid kit (including bandages, antiseptic wipes, pain relievers, anti-diarrhoeal medication), sun protection, and safe sex practices. Advised caution regarding stray animals due to rabies risk.
---
Plan
- Vaccines recommended and administered or referred for: Hepatitis A (1st dose administered), Typhoid (administered), Japanese Encephalitis (1st dose administered), Tetanus booster (administered). Patient referred for 2nd dose of Japanese Encephalitis in 28 days.
- Prescribed medications for travel: Atovaquone/proguanil 250mg/100mg, 14 tablets, for malaria prophylaxis.
- Over-the-counter medications recommended: Loperamide, oral rehydration salts, paracetamol, and a broad-spectrum insect repellent.
- Travel insurance was advised: Strongly advised to obtain comprehensive travel insurance covering medical emergencies and repatriation.
- discussed mosquito avoidance, given advice on mosquito repellent, rabies prevention/management and malaria risk regions
- discussed other health advice and advised to seek medical care if needed
- patient was sent links for South African-based travel health resources (e.g. NICD, Department of Health) and shown where to monitor health alerts
---
Follow-Up
- Follow-up actions or appointments: Patient to return on 1 November 2024 for the second dose of Japanese Encephalitis vaccine.
---
Note:
Vaccines were administered by the practice nurse with thanks.
Patient remained for 15 minutes post-vaccination to monitor for immediate allergic reactions.